Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2026 ASCO Presentation
Go back to Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2026 ASCO Presentation| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 9.65 +0.65 (7.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.00 | 52 Week High | $19.41 | |||
| Open | $8.89 | 52 Week Low | $4.83 | |||
| Day High | $9.70 | P/E | N/A | |||
| Day Low | $8.78 | EPS | $-2.74 | |||
| Volume | 711,994 | |||||
